Electroporation is a powerful and broadly applicable delivery method, yet quite a few primary and difficult-to-transfect cell types still suffer from low efficiency, poor recovery, or excessive cell death. EZ-Electro™ addresses these limitations.Designed to complement electroporation workflows, EZ-Electro™ enhances intracellular nucleic acid trafficking to deliver higher expression, improved viability, and consistent performance in challenging cell types. How EZ-Electro™ Works EZ-Electro™ employs a dual-component solution that optimizes nucleic acid delivery beyond membrane permeabilization: Tube A — Enhanced Nuclear UptakeA specially formulated solution promotes efficient nuclear uptake of nucleic acids following transient membrane disruption. (Optional) Tube B — Stabilized Nucleic Acid in Cytoplasm A proprietary blend of factors reduces nucleic acid degradation in cell lines with strong DNA sensing/degradation pathways. Together, these synergistic components improve gene transfer efficiency while supporting membrane recovery and cell viability, enabling robust and reproducible electroporation outcomes—even in primary and historically hard-to-transfect cells, outperforming conventional electroporation systems. Blow are representative results of electroporation in the absence or presence of EZ-ElectroTM for historically challenging cells such as THP-1 and primary T cells.
Related
Related